Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Bevacizumab/talaporfin/temozolomide

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Fukami S, et al. Photodynamic therapy using talaporfin sodium for sub-totally resectable malignant glioma. Photodiagnosis and Photodynamic Therapy 45: Feb 2024. Available from: URL: https://dx.doi.org/10.1016/j.pdpdt.2023.103869 Fukami S, et al. Photodynamic therapy using talaporfin sodium for sub-totally resectable malignant glioma. Photodiagnosis and Photodynamic Therapy 45: Feb 2024. Available from: URL: https://dx.doi.org/10.1016/j.pdpdt.2023.103869
Metadaten
Titel
Bevacizumab/talaporfin/temozolomide
Lack of efficacy
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56729-5

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Thiamazole

Case report

Multiple drugs

Case report

Ketamine